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ABSTRACT 
 
Context Insufficient maternal protein intake 
has been postulated to cause impaired fuel 
metabolism and diabetes mellitus in adult 
mammalian progeny, but the mechanism 
remains unclear. 
 
Objective  To investigate the effect of a 
maternal low protein whey-based diet during 
pregnancy and lactation on pancreatic 
function and skeletal muscle glucose 
metabolism in the offspring. 
 
Animals Sprague-Dawley rats: 8 mothers and 
46 offspring. 
 
Design Female rats were fed throughout 
pregnancy and lactation with otherwise-
complete isoenergetic diets sufficient (20% 
whey protein; control: n=3) or insufficient 
(5% whey protein; low-protein: n=5) in whey 
protein. From weaning all offspring ate 
control diet. 
 
Main outcome measures  Food intake and 
weight gain were measured for both mothers 
and offspring, and in vitro functional studies 
of endocrine pancreas and skeletal muscle 
were performed on offspring at 40 and 50 
days of age, respectively. 
 
Results  Food intake (P=0.004) and weight 
gain (P=0.006) were lower in low protein than 
control mothers during early gestation. 
Offspring of low protein mothers had 
significant lower body weight  from 5 to 15 
days of age, although there was no significant 
difference in food consumption. Glucose, 
arginine- and glucose/arginine-stimulated 
insulin secretion from perfused pancreases 
isolated from low protein offspring were 
decreased by between 55 and 65% compared 
with control values. Studies in skeletal muscle 
demonstrated no difference in insulin 
sensitivity between the two groups. 
 
Conclusions  Dietary whey protein 
insufficiency in female rats during pregnancy 
and lactation can evoke major changes in 
insulin secretion in progeny, and these 
changes represent a persistent functional 
abnormality in the endocrine pancreas. 
 
 
INTRODUCTION 
 
Programming [1, 2] is a process whereby poor 
nutrition at an early age leads to permanent 
changes in an organism [2]. Early adaptations 
to nutritional stress permanently alter the 
physiology and metabolism of an organ, such 
that these changes continue to be expressed in 
the absence of the original causative events 
[3]. In humans, such changes are postulated to 
be causative of later disease, including 
coronary heart disease [4, 5], depression [6], 
and the so-called “metabolic syndrome” [1], 
which refers to the grouping of type 2 
diabetes mellitus [1, 2], cardiovascular 
disease [7] and hypertension [8]. JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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Timing of the nutritional stress appears to be 
critical, with earlier events more likely to 
cause changes which persist throughout the 
life of the organism [9]. Therefore, foetal and 
early neonatal life represent developmental 
stages of particular interest. In rodents, it has 
been well established that low maternal 
protein intake during gestation can result in 
low birth weight and subsequently leads to 
various metabolic disturbances in adulthood, 
including high blood pressure, impaired 
glucose tolerance, insulin resistance and 
altered pancreatic morphology and function 
[10, 11, 12, 13, 14]. Additional studies are 
warranted to explore the relationships linking 
protein nutrition in early life to the postnatal 
development of disease in animals, as a model 
for the human condition [11]. Protein is 
important in foetal growth and pancreatic 
development [15], and is often scarce and 
expensive in communities with a high 
prevalence of diabetes and the metabolic 
syndrome [16]. 
A number of comparable studies have been 
published in which casein-based diets are 
used, but there is very little literature 
investigating a whey-based diet. Whey 
protein is considered to be of higher 
nutritional quality than casein [17]. 
Our hypothesis was that a decreased whey 
protein intake in the maternal diet (maternal 
low protein) during pregnancy and lactation 
results in a metabolic insult in the offspring 
during these periods sufficient to cause 
impaired pancreatic function and altered 
glucose metabolism in the offspring once 
adult, and that the higher quality of the whey 
protein (compared with casein) would be 
insufficient to mitigate the low-protein insult. 
Female rats were fed diets either sufficient or 
insufficient in whey protein through gestation 
and lactation, and pancreatic function (the 
secretory response to stimuli in isolated 
perfused pancreases) and glucose metabolism 
(insulin-stimulated uptake of glucose into 
glycogen in the isolated soleus muscle) were 
studied in the offspring. 
 
 
 
MATERIALS AND METHODS   
Animals and Diet   
Virgin female Sprague-Dawley rats were kept 
at 21±1ºC, subjected to a 12:12 h light:dark 
cycle. Diet was standard laboratory chow 
(18.5% crude protein, 5% fat; NRM diet 86, 
NRM New Zealand Ltd., Auckland, New 
Zealand) supplied ad libitum prior to mating. 
Females in oestrus were randomly selected 
and mated with one of three males. Dams 
were assigned such that offspring of each 
male would be represented in both 
experimental diet groups, to ensure any 
observed results were not due to a simple 
genetic effect. A positive pregnancy was 
determined by the appearance of a vaginal 
plug (defined as day 1 of gestation), at which 
stage the rats were transferred to individual 
cages. Throughout gestation and lactation rats 
were fed isoenergetic semi-synthetic diets 
containing either 20% whey protein (control), 
or 5% whey protein (low-protein) (Table 1). 
Diets were prepared in the laboratory from 
commercially available ingredients, and 
compositional analyses were performed on 
the diets (Table 1). A control diet of similar 
Table 1. Composition and analysis of experimental 
diets (g/100 g diet). 
Maternal diet  
Control Low-
protein
Ingredient 
- Cellulose 
- Cornflour 
- DL-methionine 
- Mineral mix 
- Whey protein 
- Vegetable oil 
- Sucrose 
- Vitamin mix 
 
5.0 
47.8 
0.2 
3.9 
20.0 
7.0 
15.0 
1.1 
 
5.0
62.8
0.2
3.9
5.0
7.0
15.0
1.1 
Analysis 
- Nitrogen 
- Total protein 
- Lipid 
- Carbohydrate 
- Net metabolisable energy (MJ/kg diet) 
 
3.0 
19.1 
7.7 
73.4 
16.9 
 
0.9
5.7
7.3
87.0
17.1
Diets were prepared by the authors using commercially 
available ingredients listed in the table. JOP. J Pancreas (Online) 2008; 9(4):477-488. 
JOP. Journal of the Pancreas - http://www.joplink.net - Vol. 9, No. 4 - July 2008. [ISSN 1590-8577]  479
composition has been previously reported 
[18]. During gestation, animals were not fed 
ad libitum. Instead, the amount fed daily to 
each pregnant rat was calculated from the 
body weight of the rat and the particular day 
of gestation. This calculation was based on 
food intake data from a previous feeding trial 
for mothers fed standard laboratory chow 
(data not shown), with the food restriction 
being applied to prevent low protein mothers 
consuming more than control mothers during 
gestation, as has been previously observed 
[19]. All animals had free access to water. 
Following spontaneous delivery of pups (day 
22-23 of gestation), mothers were maintained 
on the same diet as had been supplied during 
gestation, without restriction on intake. No 
restriction was applied during lactation 
because observations suggest that higher food 
intake in low protein mothers does not occur 
during this period [19, 20]. At 21 days of age, 
pups from all litters were weaned onto the 
control diet, and this was supplied ad libitum 
for the remainder of the trial. 
 
Dietary Analysis 
 
Nitrogen determination was by the 
instrumental combustion method (Nitrogen 
Analyser Series 1500, Carlo Erba, Serono, 
Italy), lipid determination by the Soxhlet 
method [21], and carbohydrate determination 
by an enzymatic and spectrophotometric 
method [22, 23]. Acid stable amino acids 
were analyzed by acid hydrolysis, sulfur 
amino acids by performic acid oxidation 
followed by acid hydrolysis [24]. Protein was 
calculated from the nitrogen content (Nx6.38) 
[25, 26], and total energy as net metabolisable 
energy was calculated from the individual 
components as has previously been described 
[27]. 
 
Food Intake, Body Weight and Feeding 
Efficiency 
 
Maternal food intake and body weight were 
measured daily from the first day of gestation 
until 21 days post-partum (weaning). 
Gestation was divided into two equal periods 
(equivalent to the first and second trimesters 
of human pregnancy [28, 29]) in order to 
determine if any observations in the offspring 
were due to differences in maternal intake or 
body weight during a specific part of 
gestation. 
Offspring body weight was measured daily 
from birth until 50 days of age, while food 
intake (determined as mean intake per rat 
within a litter) was measured daily from 
weaning until 50 days of age. Feeding 
efficiency for both mothers and offspring was 
calculated as the efficiency of energy 
utilization (EEU; total weight gain / total 
energy intake, g/kJ) as previously reported 
[30]. 
 
Isolation and Perfusion of the Pancreas 
 
Non-fasted offspring (both male and female) 
were used as pancreas donors (age at 
experimentation 42±2 days). A total of 5 (2 
litters) and 8 (3 litters) animals were used 
from the control and low protein groups, 
respectively. After initial anaesthesia by 
halothane induction (5% plus 2 L/min O2) an 
intra-peritonal injection of sodium 
phenobarbitone (Nembutal
®, Sigma, St Louis, 
MO, USA) 50 mg/kg body weight) was 
performed and animals maintained on oxygen 
during subsequent removal of the pancreas. 
Pancreases were prepared according to the 
method of Grodsky and Fanska [31], with 
minor modifications. Briefly, the pancreas, 
stomach, and duodenal remnant were isolated 
en bloc, the aorta and portal vein cannulated, 
and the preparation transferred to a perfusion 
chamber. Perfusion was performed 
simultaneously through the coeliac and 
superior mesenteric arteries (flow rate 1.2 
mL/min) and effluent was collected without 
recycling from the cannulated portal vein. The 
perfusion medium was modified Krebs-
Henseleit buffer (final concentrations: NaCl, 
112.8 mmol/L; KCl, 4.4 mmol/L; KH2PO4, 
1.5 mmol/L; MgSO4, 1.2 mmol/L; CaCl2, 2.3 
mmol/L; NaHCO3, 2.93 mmol/L; D-glucose, 
3 mmol/L), supplemented with dextran (4% 
(w/v), molar weight 71,400, industrial grade; 
Sigma, St Louis, MO, USA) and albumin 
(0.5% (w/v), bovine fraction V; A-6793, 
Sigma, St Louis, MO, USA). Buffer was 
sterile filtered (0.2 µm; Vacucap, Gelman, JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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Ann Arbor, MI, USA) before equilibration 
against a gas phase of 95% O2/5% CO2 (BOC 
Gases NZ Ltd., Auckland, New Zealand), and 
had a final pH of 7.4 at 37°C. 
 
Stimulation of the Pancreas and Sample 
Collection 
 
Organs were equilibrated for 20 min. For 90 
min thereafter portal vein effluent fractions 
were collected at 1 min intervals and stored 
on ice. Each gland was stimulated during the 
experiment by means of side arm infusions 
(0.05 mL/min) with either glucose (final 
concentration 21.7 mmol/L), arginine (final 
concentration 10.85 mmol/L), or a mixture of 
the two. Both glucose and lactate were 
measured simultaneously on every second 
sample with a glucose/lactate analyser (YSI 
2300 Stat Plus, Yellow Springs Instrument 
Co., Yellow Springs, OH, USA); glucose to 
ensure that the final perfusate concentration 
was as expected, and lactate to confirm 
pancreas viability [32]. Samples were stored 
at -80°C until analysis for insulin and amylin 
content. 
 
Insulin Radioimmunoassay 
 
Perfusate insulin concentration was 
determined in duplicate at each point using a 
double antibody RIA. Briefly, antibodies were 
raised against bovine insulin in guinea pigs. 
Radiolabelled tracer (
125I-insulin) was 
prepared by iodination of bovine insulin using 
the chloramine-T method [33], and purified 
by gel filtration chromatography. The 
standard curve was generated using serial 
dilutions of soluble human insulin (Actrapid, 
Novo Nordisk, Copenhagen, Denmark) as a 
standard. The minimum detectable 
concentration was 16 pmol/L, the linear range 
140-1,800 pmol/L, and the mean within-assay 
coefficient of variation 19% at the EC50. 
Duplicate 50 µL samples of standards or 
unknowns were incubated with 200 µL of 
antiserum (diluted 1/100,000 in RIA buffer 
(0.05 mol/L phosphate buffer, 0.1% (v/v) 
sodium azide, 0.5% (w/v) bovine serum 
albumin, pH 7.4)). After 5 h at room 
temperature, 100 µL of tracer (diluted in 
insulin RIA buffer to give a reading of 
approximately 9,000 cpm/100 µL) was added 
and incubated for 48 h. One hundred µL of 
goat anti-guinea pig IgG (diluted 5/100 (v/v) 
in RIA buffer), and 100 µL of normal guinea 
pig serum (1/100 (v/v) in RIA buffer) were 
added and incubated for 1 h at room 
temperature. One mL of polyethylene glycol 
6000 (6% (w/v) in 0.05 mol/L phosphate 
buffer, pH 7.4) was added, followed by 
further incubation for 90 min at 4°C. Tubes 
were spun at 1500 g for 30 min, decanted and 
counted for 1 min in a gamma counter 
(Wizard
TM, Wallac, Turku, Finland). 
 
Amylin Radioimmunoassay 
 
Perfusate amylin concentration was measured 
in duplicate at each point using an in-house 
RIA (M. Stokjovic, unpublished results). 
Amylin antibodies were raised in rabbits 
using synthetic rat amylin (Bachem AG, 
Bubendorf, Switzerland). Radiolabelled tracer 
(
125I-rat amylin) was prepared by iodination 
of purified synthetic rat amylin (Bachem AG, 
Bubendorf, Switzerland) using the 
chloramine-T method [33], and purified by 
gel filtration chromatography. The assay was 
standardised using lyophilised rat amylin 
standards (Peninsula Laboratories, Belmont, 
CA, USA). The minimum detectable 
concentration was 25 pmol/L, the linear range 
25-250 pmol/L, and the mean within-assay 
coefficient of variation 22% at the EC50. 
Duplicate 100 µL samples of standards or 
unknowns were incubated with 100 µL of 
antiserum (diluted 1/100,000 in RIA buffer 
(0.05 M phosphate buffer, 3.1 mmol/L 
sodium azide, 0.25% (w/v) bovine serum 
albumin, 0.1% (v/v) Triton X-100, 25 mmol/L 
EDTA, 1% aprotonin, pH 7.4). After 24 h at 
4°C, 100 µL of tracer (diluted in amylin RIA 
buffer to give a reading of approximately 
9,000 cpm/100 µL) was added and incubated 
for 48 h (4°C). One hundred µL of goat anti-
rabbit IgG diluted 1/15 (v/v) in buffer and 100 
µL of normal rabbit serum diluted 1/100 (v/v) 
were added and incubated for 1 h at room 
temperature. Polyethylene glycol 6000 (0.5 
mL, 8% (w/v) in 0.05 mol/L phosphate 
buffer) was then added followed by a further 
incubation for 90 min at 4°C. Samples were JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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centrifuged at 1,500 g at 4°C for 30 min, 
decanted and counted for 1 min in a gamma 
counter. Data analysis for both assays used 
Multicalc
TM software version 2.0 (Wallac, 
Turku, Finland). 
 
Insulin-Stimulated Uptake of Glucose into 
Muscle Glycogen 
 
Male and female offspring (13 animals from 
three litters for control group, and 20 animals 
from four litters for low protein group; age: 
50±2 days) were starved overnight (16-18 h) 
with free access to water. An intra-peritoneal 
injection of sodium phenobarbitone (80 
mg/kg body weight; Nembutal
®, Sigma, St 
Louis, MO, USA) was administered, and the 
animals sacrificed by cervical dislocation 
once the anaesthetic had taken effect. The 
soleus muscle was removed from each leg 
under Krebs-Henseleit buffer (final 
concentrations (mmol/L): NaCl, 118.5 
mmol/L; KCl, 4.75 mmol/L; MgSO4, 1.18 
mmol/L; NaHCO3, 24.8 mmol/L; KH2PO4, 
1.18 mmol/L; CaCl2,  2.54 mmol/L; D-
glucose, 10 mmol/L) saturated with 95% 
O2/5% CO2. Each soleus muscle was then 
split longitudinally into two or three strips, 
depending on the muscle diameter. After 20 
min equilibration in a separate container of 
95% O2/5% CO2-saturated Krebs-Henseleit 
buffer, up to five strips were transferred to a 
50 mL Erlenmeyer flask in a 30°C shaking 
waterbath. Each flask contained 10 mL of 
normal Dulbecco’s Modified Eagle Medium 
with one of the following concentrations of 
insulin: 0, 0.71, 2.37, 7.1, 23.7, 71.0, 237.0 
nM. Exactly 2 min after the transfer of muscle 
strips to the flask, 10 µL of a 1.85 MBq/mL 
solution of U-
14C-D-glucose (American 
Radiolabeled Chemicals Inc., St Louis, MO, 
USA) were added, and the flask incubated for 
a further 2 h at 30°C under a constant stream 
of 95% O2/5% CO2. Each muscle strip was 
then snap-frozen in liquid nitrogen and 
freeze-dried for a minimum of 24 h. 
 
Glycogen Extraction from Soleus Muscle 
and Scintillation Counting 
 
Freeze-dried muscle was digested in 250 µL 
of 60% (w/v) KOH for 45 min at 70°C and 
the glycogen precipitated by addition of 750 
µL cold 95% ethanol. Samples were kept at -
20°C overnight then centrifuged (10,000 g, 15 
min, 4°C) and the supernatant aspirated. The 
pellet was washed in 750 µL cold 95% 
ethanol, centrifuged and the supernatant 
aspirated. The wash step was repeated once 
more and the glycogen pellet dried at 60°C 
for 2 h. Glycogen was redissolved in 200 µL 
deionized water and transferred to a 
scintillation tube. StarScint
® (Canberra 
Packard, Pangbourne, Berkshire, UK) 
scintillation fluid (1.8 mL) was added and the 
sample counted for 5 min (LS 3801 beta-
counter, Beckman Coulter Inc., Fullerton, 
CA, USA). 
 
Collection of Blood and Plasma 
Measurements 
 
Blood was collected into lithium heparin 
vacutainers immediately post mortem from 
the vena cava of animals sacrificed for the 
removal of soleus  muscle. Plasma was 
separated from the red cells and stored at -
85°C until measurements were performed. 
Glucose and lactate concentration (control: 13 
animals from three litters; low protein: 13 
animals from four litters) was measured using 
a glucose/lactate analyzer (Yellow Springs 
Instrument Corp., Yellow Springs, OH, 
USA), while cholesterol and triacylglycerol 
(control: 9 animals from three litters; low 
protein: 3 animals from four litters) were 
determined using a Cobas Mira analyzer 
(Roche, Basel, Switzerland). 
 
ETHICS 
 
All experiments performed were approved by 
the University of Auckland Animal Ethics 
Committee. 
 
STATISTICS 
 
All statistical analyses were performed using 
GenStat
® for Windows 5
th edition or 6
th 
edition (GenStat
® Release 4.22, PC/Windows 
XP, Lawes Agricultural Trust, Rothamsted 
Research, Harpenden, Hertfordshire, United 
Kingdom, Version 6.1.0.210). Unless 
otherwise stated, analysis was a linear mixed 
model residual maximum likelihood (REML), JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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with diet being the fixed effect and litter the 
random effect. Unless otherwise stated, data 
are presented as the mean value for each of 
the control and low protein groups, with the 
mean and standard error  of the difference 
(difference±SE) for the comparison between 
the two groups. Graphs show mean values 
and standard deviations (SD). 
For the insulin-stimulated uptake of glucose 
into glycogen, a four-parameter logistic curve 
was fitted to the data with the equation: 
y = ( a - b ) / ( 1 + (insulin/c) 
d ) + b 
where the parameters were defined as 
follows: 
a is the asymptote as x tends to 0 for all d 
greater than 0 (i.e. the minimum value); 
b is the asymptote as x diverges (i.e. the 
maximum value); 
c is the predicted response midway between 
the asymptotes (i.e. the effective insulin 
concentration at which the half-maximal 
response occurs (EC50)); 
d is a function of the rate of change (or slope) 
of the fitted curve at the point of inflection. 
Because the maternal diet was altered, the 
experimental unit in all cases was the litter; 
thus, the effective number of observations for 
each experiment was determined by the 
number of litters rather than the number of 
individual offspring. A two-tailed probability 
lower than 0.05 indicated a significant 
difference between treatments.   
RESULTS   
Maternal Food Intake, Body Weight and 
Feeding Efficiency 
 
Food intake in the low protein group was 
significantly lower than the control group 
during the first half of gestation (control: 248 
g; low protein: 219 g; difference±SE: -29±11 
g; P=0.004) (Figure 1a). As with food intake, 
energy intake (net metabolisable energy) 
during the first period of gestation was 
significantly lower in the low protein mothers 
compared to those in the control group 
(control: 4,197 kJ; low protein: 3,708 kJ; 
difference±SE: -489±186 kJ; P=0.008). 
Total weight gain of the mothers through 
gestation in the low protein group was lower 
than that in the control group (control: 117 g; 
low protein: 78 g; difference±SE: -39±9 g; 
P<0.001), primarily due to a difference during 
the first half of gestation (control: 40 g; low 
protein: 10 g; difference±SE: -30±11 g; 
P=0.006) (Figure 1b). Weight change showed 
no difference during the second half of 
gestation (control: 77 g; low protein: 68 g; 
difference±SE: -9±8 g; P=0.285) or through 
lactation (control: -23 g; low protein: -18 g; 
difference±SE: 5±15 g; P=0.766). 
Figure 1. Food intake and body weight of female
Sprague-Dawley rats fed through gestation and
lactation with diets varying in protein content. Data
represent mean values±SD for daily food intake (a.), 
and for change in body weight from the first day of
gestation (b.). Mothers were fed iso-energetic diets
(prepared in our laboratory) containing either 20%
(control: filled circle) or 5% (low-protein: open circle)
whey protein through gestation and lactation. The
numbers within brackets above each figure represent
the trimester of human gestation to which each
indicated period is equivalent. The total number of
observations was 5 and 6 mothers for the control and 
low-protein groups, respectively. P values indicate the
trimester equivalents during which there was a
significant difference between the two diet groups. JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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Feeding efficiency (EEU: efficiency of energy 
utilization) was significantly lower in the low 
protein group than the control group during 
gestation (control: 0.015 g/kJ; low protein: 
0.011 g/kJ; difference±SE: -0.004±0.001 g/kJ; 
P<0.001) and lactation (control: 0.015 g/kJ; 
low protein: 0.008 g/kJ; difference±SE: -
0.007±0.002 g/kJ; P<0.001). As with weight 
gain and food intake, the overall difference 
during gestation was mainly due to a 
significant difference during the first half of 
gestation (control: 0.009 g/kJ; low protein: 
0.003 g/kJ; difference±SE: -0.006±0.003 g/kJ; 
P=0.016). The calculation for lactation 
included the weight gain by offspring during 
this period, as offspring growth was 
dependent on maternal food intake. 
 
Offspring Food Intake and Body Weight 
 
There was a small but significant (ranging 
from P=0.003 to P=0.049 for the comparison 
on each day) difference in body weight of the 
offspring between day 5 and day 15 inclusive, 
with the low protein offspring weighing less 
than those in the control group (Figure 2b). 
There was no significant difference with 
respect to birth weight (control: 5.4 g; low 
protein: 5.4 g; difference±SE: 0.0±0.4 g; 
P=0.990), total weight gain (control: 97 g; 
low protein: 92 g; difference±SE: -5±11 g; 
P=0.641), or rate of weight gain either pre-
weaning (control: 1.2 g/day; low protein: 1.0 
g/day; difference±SE: -0.2±0.2 g/day; 
P=0.257) or post-weaning (control: 2.7 g/day; 
low protein: 2.8 g/day; difference±SE: 
0.1±0.8 g/day; P=0.760) between the two 
groups (Figure 2b). There was no difference 
between the two groups in terms of offspring 
Figure 2. The effect of protein level in the maternal
diet during gestation and lactation on food intake and
body weight of offspring. Data represent mean
values±SD for daily food intake (a.) and body weight
(b.) of offspring of mothers fed isoenergetic diets
(prepared in-house) containing either 20% (control:
filled circle) or 5% (low-protein: open circle) whey
protein through gestation and lactation. All offspring
were weaned (indicated by the dashed vertical line)
onto diet control. The total number of litters was 5 for
control and 6 for low protein groups. There was no
significant difference in pre-weaning weight gain, or 
post-weaning weight gain or food intake, between the
two diet groups. 
Table 2. Insulin secretion by perfused pancreases isolated from offspring of female rats fed through gestation and 
lactation with diets varying in protein content. 
Maternal diet   
Control Low-protein 
Difference±SE 
 
P value
 a 
Stimulus  Glucose 
Arginine 
Glucose + arginine 
57 pmol 
13 pmol 
87 pmol 
20 pmol 
5 pmol 
38 pmol 
-37±9 pmol 
-8±4 pmol 
-49±20 pmol 
<0.001 
0.044 
0.013 
Total insulin secretion  162 pmol  64 pmol  -98±28 pmol  <0.001 
Mean basal insulin secretion  0.16 nmol/L  0.05 nmol/L  -0.11±0.04 nmol/L  0.005 
a Linear mixed model residual maximum likelihood (REML)JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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food intake (Figure 2a; control: 225 g; low 
protein: 203 g; difference±SE: -22±19 
g;P=0.257). 
 
Pancreatic Hormone Secretion 
 
Table 2 shows the effect of maternal diet on 
the secretion of insulin from the isolated 
perfused pancreas. Total insulin secretion, 
mean basal insulin secretion and secretion in 
response to each of the three stimulations 
(glucose, arginine, and glucose plus arginine) 
were significantly reduced in low protein 
offspring. In the case of the response to 
glucose, both first-phase (control: 27 pmol; 
low protein: 9 pmol; difference±SE: -18±5 
pmol; P<0.001) and second-phase (control: 30 
pmol; low protein: 11 pmol; difference±SE: -
19±11 pmol; P=0.001) secretion were reduced 
in the low protein group, while in the 
response to arginine, only the second-phase 
secretion was reduced (control: 5.3 pmol; low 
protein: 2.2 pmol; difference±SE: -3.1±1.4 
pmol; P=0.025). In the case of the stimulation 
by the combined glucose plus arginine 
solution, the low protein offspring showed a 
loss of first-phase insulin secretion, both as a 
significant decrease compared to the control 
group (control: 34 pmol; low protein: 11 
pmol; difference±SE: -23±7 pmol; P<0.001) 
and first-phase as a percentage of total 
secretion resulting from this stimulus (control: 
40%; low protein: 30%; difference±SE: -
10±2%; P<0.001). 
Neither amylin secretion, nor the ratio of 
amylin/insulin, showed any significant 
difference between the two diet groups (data 
not shown). 
 
Insulin-Stimulated Uptake of Glucose into 
Muscle Glycogen 
 
Glucose uptake into soleus muscle glycogen 
was not significantly different in low protein 
animals compared to those in the control 
group at any point of the dose-response curve 
(Figure 3). There was no significant 
difference between the two groups with 
respect to minimum (P=0.459), maximum 
(P=0.842), EC50 (P=0.302) or slope (P=0.362) 
as determined by four-parameter logistic 
curve fitting. 
 
Plasma Measurements 
 
There was no difference between offspring of 
the two diet groups in terms of plasma levels 
of glucose (control: 4.3 mmol/L; low protein 
6.7 mmol/L; difference±SE: 2.4±2.0 mmol/L; 
P=0.241), lactate (control: 4.1 mmol/L; low 
protein: 4.9 mmol/L; difference±SE: 0.8±0.8 
mmol/L; P=0.301) or cholesterol (control: 2.1 
mmol/L; low protein: 2.2 mmol/L; 
difference±SE: 0.1±2.3 mmol/L; P=0.808), 
but low protein offspring had a significantly 
lower plasma triacylglycerol concentration 
(control: 0.93 mmol/L; low protein: 0.50 
mmol/L; difference±SE: -0.43±0.13 mmol/L; 
P=0.001) than control offspring. 
 
DISCUSSION 
 
In general, the pattern of food intake and body 
weight observed in the low protein mothers 
was as has been reported. A sharp decline in 
intake over the last days of gestation in the 
low protein group [34] was reflected in the 
slowing of weight gain towards the end of 
gestation [19], while the low intake during 
lactation [19, 35] caused a loss of weight 
Figure 3. Incorporation of 
14C-glucose into soleus
muscle glycogen of offspring of Sprague-Dawley 
females fed diets differing in protein content during 
gestation and lactation. Rates of 
14C glucose uptake 
into glycogen were determined in rat soleus muscle 
isolated from the offspring of mothers fed diets 
sufficient (20% whey protein; control: filled circle) or 
insufficient (5% whey protein; low-protein: open 
circle) in protein. Data represent the mean value±SD 
for 13 animals from three litters for control group, and 
20 animals from four litters for low-protein group. 
There was no significant difference between the two 
groups at any insulin concentration. JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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through lactation [19]. Food intake in the low 
protein group during gestation was unusual in 
that it tended to be less than in the control 
group; therefore, there was no evidence of 
compensatory feeding [19, 20]; the restriction 
on intake imposed during gestation seems to 
have been unnecessary in this case. In fact, 
the lower maternal food (and therefore 
energy) intake in the low protein group means 
that the offspring of these dams were exposed 
to both caloric and protein restriction during 
early gestation. Although the caloric 
restriction was much less than the protein 
restriction, we cannot exclude the possibility 
that this has influenced the outcomes reported 
here. In future studies we would employ a 
more strict dietary regime such that caloric 
intake was the same for both diet groups. 
The observed food intake of the control group 
mothers was unusual. While the decline in 
food intake for control rats before parturition 
(similar to that seen in the low protein group) 
is routinely observed, the magnitude of this 
decline, and the low intake throughout 
lactation, are at variance with our own studies 
using standard laboratory chow (data not 
shown), and previously reported data [36, 37]. 
This suggests that the protein content of the 
diet is not the only factor controlling food 
intake. The pattern of maternal body weight 
in the control group reflected the pattern of 
food intake, with a slowing in growth rate at 
the end of gestation and an average weight 
loss of over 20 g per dam through lactation, 
neither of which have been observed in 
previous studies using a similar diet [20, 36]. 
Offspring in both diet groups (all of which 
were weaned onto control diet) consumed 
similar amounts of food through the duration 
of the trial, but this amount was significantly 
less than we observed in animals fed standard 
laboratory chow (data not shown). Body 
weight in both groups was similar, with the 
slightly lower weight observed in the low 
protein group from day 5 to day 15 
presumably a reflection of the tendency to 
lower food consumption in the low protein 
mothers through lactation. In both cases, body 
weight was significantly less than previously 
reported values [20]. 
In the isolated perfused pancreas, low protein 
offspring showed evidence of impaired 
pancreatic function in response to the main 
insulin secretagogue (glucose) and a 
membrane depolarizing agent (arginine). In 
this particular experiment, there was a 
significant difference in each of the 
stimulations applied to the pancreas. The loss 
of glucose-induced insulin secretion is in 
agreement with previous studies showing a 
decreased insulin secretion both in vivo and 
using an in vitro isolated islet system [38]. 
There was also an impairment of first-phase 
insulin secretion in response to a combined 
glucose/arginine stimulation. A loss of first 
phase glucose-induced insulin secretion is a 
feature of the early stages of type 2 diabetes 
[39, 40] and could be due to either exhaustion 
of the labile pool of insulin granules or a 
time-dependent inhibition of the secretion 
response [39]. There is evidence that the islet 
size, proliferative capacity and vascularization 
[15], as well as the amount of beta cells 
within each islet and the percentage of islet 
tissue and beta cells within the pancreas [41] 
are all reduced in the pancreases of offspring 
of rat dams fed a low protein diet during 
gestation [15, 41] and/or lactation [41]. The 
lower insulin secretion observed in low 
protein offspring may be due to one or more 
of these factors. 
Previous studies show an inhibitory effect by 
amylin on insulin secretion [42, 43] at a 
concentration as low as 75 pmol/L, and it was 
for this reason that amylin secretion was 
measured. Secretion levels higher than 100 
pmol/L were observed in low protein 
offspring during the basal phase, although 
there was considerable variation between 
animals. Because of this variability, it is 
unclear whether or not amylin is impairing the 
insulin secretion from low protein offspring. 
Additional studies employing, for example, a 
specific amylin antagonist such as the 
amylin
8-37 molecule (a truncated peptide of 
native rat amylin in which the first seven 
amino acids are absent) [44] would be helpful 
in clarifying this. 
A number of studies have been performed 
which suggest that an increase in peripheral JOP. J Pancreas (Online) 2008; 9(4):477-488. 
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insulin sensitivity in the offspring of protein-
restricted rats may be an adaptive response to 
a reduction of insulin secretion. These include 
both low protein [45] and protein-free [46] 
diets during early lactation only, and low 
protein during both gestation and lactation 
[38]. However, in the current study, there was 
no evidence of an increase in insulin 
sensitivity in the low protein offspring. The 
reasons for this observation are unclear; it 
would be expected that decreased insulin 
secretion would lead to a higher plasma 
glucose concentration in the absence of any 
change in insulin sensitivity. No such change 
in plasma glucose was observed, although the 
insulin sensitivity of tissues such as liver and 
adipose was not measured in the experiments 
reported here. Further studies incorporating 
such measurements are required to clarify this 
issue. 
Finally, the observation that fasting plasma 
triacylglycerol levels were lower in low 
protein offspring is in agreement with 
previous studies [47], suggesting that in this 
instance a maternal low protein diet during 
gestation and lactation may program risk for 
diabetes, but not for vascular disease, as may 
be the case for early human undernutrition. 
The possibility cannot be excluded that 
changes relevant to vascular disease may 
occur after 50 days of age, the point at which 
these experiments ended. 
 
CONCLUSION 
 
Overall, these results show a decrease in 
pancreatic insulin secretion in the offspring of 
female rats fed a low whey protein diet during 
gestation and lactation; such a decrease is 
associated with the early development of type 
2 diabetes in humans and suggestive of an 
increased susceptibility to the development of 
this disease in adult life, as has been observed 
in similar studies using casein as a protein 
source. This observation is in accordance with 
the hypothesis that the fetal/neonatal 
environment plays a role in the programming 
of type 2 diabetes. 
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